One potentially helpful, although with low-sensitivity, feature is focal and weak napsin A immunoreactivity, which can be seen in up to 15% of LCNEC [27] while SCLC is consistently negative for this marker. This evidence concerns the gene NAPSA and large cell neuroendocrine carcinoma.